Pseudomonas Genotypes Across 292 Saturation-Diver Skin Infections
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional activity, training or occupational setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.
Reader question: What did this exact study measure, in whom, with which comparator and timepoint—and which conclusions would go beyond its evidence?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | Isolates collected from 292 skin infections in operational saturation divers and about 800 environmental isolates from diving systems. |
| Design | Longitudinal microbiologic surveillance with restriction-fragment analysis and pulsed-field gel electrophoresis. |
| Comparator | Infection-derived versus saturation-environment isolates and their genotype overlap. |
| Timepoint | Collection from 1986 through 1998. |
| Key result | Of 472 analyzed isolates, 181 came from diver skin infections. Investigators defined 97 genotypes; about 25% appeared in both infections and the environment, and eight frequent infectious genotypes persisted across years. |
| Funding/conflict context | PubMed classifies the work as non-U.S.-government research support; specific funding and conflict details were not reported in the accessible abstract. |
What was actually measured?
Of 472 analyzed isolates, 181 came from diver skin infections. Investigators defined 97 genotypes; about 25% appeared in both infections and the environment, and eight frequent infectious genotypes persisted across years.
The study's denominator is isolates and recorded infections, not the number of individual divers at risk. Its strength is molecular linkage between clinical and environmental samples over many years.
The denominator defines the claim. People, visits, infections, episodes, isolates, feet and blisters are different analytic units. A percentage or rate using one unit cannot be silently rewritten as the percentage of people affected.
What the result does not prove
Repeated infections or isolates may come from the same diver, and the abstract does not provide person-time incidence. Genotype overlap supports environmental transmission but does not prove the source of every infection.
Association and timing do not automatically prove individual causation. Footwear, surfaces, climate, ultraviolet exposure, hygiene, protective equipment, training load, prior conditions, referral patterns and access to care may change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors’ conclusions, this interpretation or any product.
Infection boundary: Moisturization does not eradicate fungi or bacteria, replace culture or other diagnostic testing, or substitute for infection-control and medical treatment.
Keep the condition categories separate
Dryness, friction injury, sunburn, dermatitis, sensitization, fungal disease and bacterial infection are not interchangeable. A moisturizer may support hydration and the moisture barrier, but it does not diagnose infection, prevent ultraviolet injury, replace medical evaluation or substitute for activity-specific prevention.
Persistent spreading redness, drainage, fever, severe pain, rapidly worsening symptoms, a suspected contagious outbreak or major loss of function warrants prompt professional assessment. Clinicians may need microscopy, culture, patch testing, skin-prick testing or other targeted evaluation depending on the question.
Activity details worth documenting
- What surface, footwear, sock, glove, mat, pool, boat, uniform, animal, climate or training load preceded the change?
- Where did the problem begin, and did it change during rest, travel, deployment, competition or a different facility?
- Were towels, clothing, footwear, razors, equipment or showers shared, and how were high-touch surfaces cleaned?
- How often was skin wet, occluded, rubbed, heated, chilled or exposed to sun?
- Did the problem alter sleep, pace, attendance, training, competition, work safety or duty status?
Prevention comes before cosmetic care
Prevention should match the hazard: well-fitted and broken-in equipment, task-appropriate textiles, friction management, clean personal gear, facility hygiene, prompt showering, ultraviolet protection and timely clinical assessment. No single intervention prevents every diagnosis.
Do not share personal skin products during an outbreak and do not test workplace, sport or environmental materials directly on skin. Follow occupational-health, sports-medicine, public-health and facility instructions for contagious or exposure-related conditions.
Primary research and authoritative guidance
- Primary research record: PubMed PMID 10723043
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, infection, blisters, sunburn or sensitization; relieves pain or itch; neutralizes environmental exposures; is appropriate for every person; or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Fungal-Skin Screening in 454 Iranian Wrestlers
- Clinical Skin Findings in 1,321 Korean Military Personnel
- Sun-Safety Reports From 226 New Zealand Skiers and Snowboarders
- Hairbrush Screening in 902 Tokyo University Judo Athletes
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace, sports, military, maritime, animal-exposure or infection-control determination.